Single-case study of a secondary interdigitating dendritic cells sarcoma highlights the role of RAS mutation in trans-differentiation phenomenon and uncovers a potential efficacy of anti-CD19 CAR-T cell therapy
Related Experiment Video
Updated: Jun 23, 2026

12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
15.4K
Imane Karrat1,2, Côme Sesboue3, Audrey Gros4
1CHU de Bordeaux, Service d'hématologie Clinique et de thérapie cellulaire, Bordeaux, France.
Leukemia & Lymphoma
|November 13, 2025
Abstract
No abstract available in PubMed .

